398120 — SG HealthCare Co Income Statement
0.000.00%
- KR₩33bn
- KR₩40bn
- KR₩25bn
Annual income statement for SG HealthCare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 25,499 | 27,779 | 16,105 | 24,601 |
| Cost of Revenue | ||||
| Gross Profit | 6,189 | 7,111 | 5,158 | 7,116 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 23,740 | 25,616 | 16,790 | 23,128 |
| Operating Profit | 1,759 | 2,163 | -686 | 1,473 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -268 | 2,115 | -3,655 | 1,037 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -451 | 1,776 | -3,533 | 935 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -451 | 1,767 | -3,547 | 936 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -451 | 1,767 | -3,547 | 936 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -41.3 | 168 | -380 | 84.8 |
| Dividends per Share |